BeStock  

Kestra Medical Technologies KMTS

US equityMarket cap rank #2876Medical Instruments & Supplies
$25.10 −$1.53 (-5.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.10 0.00%
Open$26.14
Prev close$26.63
Day range$24.94 – $27.50
Volume435.1K
Market cap$1.50B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q1, ended Jul 2026

Revenue$30.97M+59.9% YoY
Operating profit-$37.66M-30.4% YoY
Net profit-$44.09M-70.7% YoY
Diluted EPS-$0.75-50.0% YoY
Free cash flow-$40.63M-17.6% YoY
Operating cash flow-$32.30M

Revenue, last 8 quarters

$14.7MOct '24$15.1MJan '25$17.2MApr '25$19.4MJul '25$22.6MOct '25$24.6MJan '26$28.6MApr '26$31.0MJul '26

Net profit, last 8 quarters

$-20.6MOct '24$-21.8MJan '25$-51.1MApr '25$-25.8MJul '25$-32.8MOct '25$-34.2MJan '26$-38.8MApr '26$-44.1MJul '26

Diluted EPS by quarter

-1.19Oct '24-0.50Jan '25-2.21Apr '25-0.50Jul '25-0.64Oct '25-0.61Jan '26-0.67Apr '26-0.75Jul '26

Free cash flow by quarter

$-22.7MOct '24$-22.5MJan '25$-31.5MApr '25$-34.5MJul '25$-25.8MOct '25$-28.4MJan '26$-28.4MApr '26$-40.6MJul '26

Annual revenue

$0.0FY20$0.0FY21$7.6MFY23$27.8MFY24$59.8MFY25$95.1MFY26

Profitability & balance sheet

Gross margin53.9%
Operating margin-134.5%
Net margin-140.4%
Return on equity-73.7%
Return on assets-48.8%
Return on invested capital-57.0%
Current ratio4.69
Liabilities / assets36.0%
Cash & investments$198.91M
Total debt$76.42M
Net cash (debt)$122.49M

Income statement

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Revenue as Reported $30.97M $95.13M $28.64M $24.55M $22.57M
Total Operating Revenue $30.97M $95.13M $28.64M $24.55M $22.57M
Cost of Revenue $13.47M $46.26M $12.96M $11.65M $11.14M
Gross Profit $17.50M $48.86M $15.68M $12.91M $11.42M
Operating Expense $55.16M $183.60M $55.03M $47.67M $43.18M
Selling and Admin Expenses $48.36M $164.12M $49.39M $42.70M $38.30M
Research & Development $6.80M $19.48M $5.63M $4.97M $4.88M
Operating Profit -$37.66M -$134.74M -$39.34M -$34.77M -$31.76M
Net Non-Operating Interest Income (Expense) $196,000.00 $805,000.00 $382,000.00 $275,000.00 -$105,000.00
Non-Operating Interest Income $2.13M $8.35M $2.23M $2.16M $1.80M
Non-Operating Interest Expense $1.93M $7.55M $1.84M $1.89M $1.90M
Other Income (Expense) -$6.58M $2.62M $319,000.00 $359,000.00 -$891,000.00
Special Income (Charges) -$6.30M – – – –
-Less:Other Special Charges $6.30M – – – –
Other Non-Operating Income (Expenses) -$272,000.00 $2.62M $319,000.00 $359,000.00 -$891,000.00
Pretax Profit -$44.04M -$131.32M -$38.64M -$34.13M -$32.75M
Tax $50,000.00 $294,000.00 $192,000.00 $35,000.00 $34,000.00
Net Profit -$44.09M -$131.61M -$38.84M -$34.17M -$32.79M
Profit from Continuing Operations -$44.09M -$131.61M -$38.84M -$34.17M -$32.79M
Net Income to Parent Company -$44.09M -$131.61M -$38.84M -$34.17M -$32.79M
Net Income to Common Stockholders -$44.09M -$131.61M -$38.84M -$34.17M -$32.79M
Basic EPS -$0.75 -$2.43 -$0.67 -$0.61 -$0.64
Diluted EPS -$0.75 -$2.43 -$0.67 -$0.61 -$0.64
Minority Interests – – – $0.00 $0.00

Balance sheet

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Assets $347.36M $358.47M $358.47M $379.34M $246.70M
Total Current Assets $226.27M $222.36M $222.36M $314.06M $195.41M
Cash and Cash Equivalents & Short-Term Investments $198.91M $196.43M $196.43M $291.32M $175.42M
-Cash and Cash Equivalents $68.56M $99.71M $99.71M $291.32M $175.42M
-Short Term Investments $130.35M $96.72M $96.72M – –
Receivables $15.41M $14.54M $14.54M $12.71M $10.41M
-Accounts Receivable $15.41M $14.54M $14.54M $12.71M $10.41M
Prepaid Assets $2.39M $1.69M $1.69M $1.71M $1.30M
Inventory $7.44M $6.71M $6.71M $6.83M $6.92M
Other Current Assets $2.12M $2.98M $2.98M $1.49M $1.36M
Total Non-Current Assets $121.08M $136.11M $136.11M $65.28M $51.29M
Net PPE $66.92M $62.45M $62.45M $57.22M $47.89M
-Gross PPE $100.78M $93.88M $93.88M $86.69M $75.66M
-Accumulated Depreciation -$33.86M -$31.43M -$31.43M -$29.48M -$27.77M
Investments and Advances $45.79M $65.77M $65.77M – –
Non-Current Prepaid Assets $1.84M $1.76M $1.76M $1.85M $1.86M
Other Non-Current Assets $6.53M $6.12M $6.12M $6.21M $1.54M
Total Liabilities $125.00M $98.81M $98.81M $91.35M $82.62M
Total Current Liabilities $48.27M $50.37M $50.37M $42.93M $35.76M
Payables $25.96M $27.30M $27.30M $24.02M $20.21M
-Accounts Payable $25.96M $27.30M $27.30M $24.02M $20.21M
Current Accrued Expenses $15.00M $9.11M $9.11M $8.66M $7.19M
Short-Term Debt and Capital Lease Obligation $23,000.00 $31,000.00 $31,000.00 $10,000.00 $53,000.00
-Current Capital Lease Obligation $23,000.00 $31,000.00 $31,000.00 $10,000.00 $53,000.00
Total Non-Current Liabilities $76.73M $48.44M $48.44M $48.42M $46.86M
Long Term Debt and Capital Lease Obligation $76.42M $46.76M $46.76M $46.54M $44.75M
-Long Term Debt $72.50M $42.65M $42.65M $42.26M $41.87M
-Long Term Capital Lease Obligation $3.93M $4.11M $4.11M $4.28M $2.87M
Derivative Product Liabilities $0.00 $1.37M $1.37M $1.75M $1.98M
Other Non-Current Liabilities $306,000.00 $306,000.00 $306,000.00 $140,000.00 $140,000.00
Total Equity $222.36M $259.66M $259.66M $287.99M $164.08M
Stockholders' Equity $222.36M $259.66M $259.66M $287.99M $164.08M
Capital Stock $59.27M $58.38M $58.38M $58.35M $51.45M
-Common Stock $59.27M $58.38M $58.38M $58.35M $51.45M
Additional Paid-In Capital $859.50M $853.35M $853.35M $842.67M $691.49M
Retained Earnings -$695.95M -$651.86M -$651.86M -$613.03M -$578.86M
Gains/Losses Not Affecting Retained Earnings -$471,000.00 -$218,000.00 -$218,000.00 – –

Cash flow

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Operating Cash Flow -$32.30M -$81.70M -$18.72M -$18.37M -$18.34M
Net cash flow from continuing operations -$32.30M -$81.70M -$18.72M -$18.37M -$18.34M
Net Income from Continuing Operations -$44.09M -$131.61M -$38.84M -$34.17M -$32.79M
Gain/Loss from Continuing Operations $6.85M -$1.51M $58,000.00 -$65,000.00 $1.12M
Depreciation & Depletion & Amortization $2.66M $8.71M $2.33M $1.98M $2.37M
Other Non-Cash Items $511,000.00 $2.20M $521,000.00 $594,000.00 $555,000.00
Change in Working Capital -$7.50M $1.78M $4.93M $2.12M $711,000.00
-Change in Receivables -$48,000.00 -$9.06M -$2.91M -$2.66M -$1.71M
-Change in Inventory -$908,000.00 -$458,000.00 $8,000.00 $130,000.00 -$136,000.00
-Change in Prepaid Assets $246,000.00 -$563,000.00 -$984,000.00 -$532,000.00 $813,000.00
-Change in Payables and Accrued Expense -$6.61M $12.50M $8.95M $5.40M $1.90M
-Change in Other Current Assets $2,000.00 $40,000.00 $10,000.00 $10,000.00 $10,000.00
-Change in Other Current Liabilities -$190,000.00 -$685,000.00 -$144,000.00 -$228,000.00 -$175,000.00
Net cash flow from investing -$21.35M -$203.28M -$172.71M -$14.92M -$7.42M
Net Cash Flow from Continuing Investing Activities -$21.35M -$203.28M -$172.71M -$14.92M -$7.42M
Net PPE Purchase and Sale -$8.34M -$35.42M -$9.67M -$9.99M -$7.50M
Net Investment Purchase and Sale -$13.02M -$168.04M -$163.04M – –
Financing Cash Flow $22.50M $147.10M -$185,000.00 $149.18M -$27,000.00
Net Cash Flow from Continuing Financing Activities $22.50M $147.10M -$185,000.00 $149.18M -$27,000.00
Net Issuance Payments Of Debt $28.61M – – – –
Cash Dividends Paid -$172,000.00 -$323,000.00 -$298,000.00 -$25,000.00 $0.00
Proceeds from Stock Option Exercised $2.44M $593,000.00 – – –
Net Other Financing Charges -$8.38M -$2.47M -$480,000.00 -$84,000.00 -$27,000.00
Ending Cash Balance $68.89M $100.04M $100.04M $291.66M $175.76M
Net Change in Cash -$31.15M -$137.89M -$191.61M $115.90M -$25.79M
Beginning Cash Balance $100.04M $237.93M $291.66M $175.76M $201.55M
Free Cash Flow -$40.63M -$117.12M -$28.39M -$28.35M -$25.84M
Deferred Tax – $166,000.00 – – –
Net Other Investing Changes – $184,000.00 $0.00 $67,000.00 $80,000.00
Net Common Stock Issuance – $149.29M $0.00 – –
Net Preferred Stock Issuance – $0.00 $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on KMTS.

Sign in to join the discussion.

Scroll to Top